Search

Search Results
Results 10351 - 10360 of 17271 for Active treatment
  • White Paper - 27 Nov 2024
    Discover how CBF assays are revolutionizing research and drug development.
  • Drug - 21 Nov 2024
    Consumer Medicine Information (CMI) about Micardis Plus intended for persons living in Australia.
  • News - 20 Nov 2024
    Published in Child Psychiatry and Human Development, a research team led by the University of Minnesota Medical School found that Creativity Camp, a two-week arts intervention delivered as a day camp,...
  • Drug - 14 Nov 2024
    Consumer Medicine Information (CMI) about Diclofenac Sodium Viatris (formerly Fenac) (diclofenac sodium) intended for persons living in Australia.
  • News - 13 Nov 2024
    Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative Alzheimer's disease treatment approaches.
  • Drug - 5 Nov 2024
    Consumer Medicine Information (CMI) about Clofen intended for persons living in Australia.
  • Drug - 31 Oct 2024
    Consumer Medicine Information (CMI) about Lumin intended for persons living in Australia.
  • News - 28 Oct 2024
    The mistakes are small but carry severe consequences: In Usher syndrome, genetic mutations cause both hearing and vision loss. Cell biologist Professor Uwe Wolfrum from Mainz University is researching...
  • Drug - 25 Oct 2024
    Consumer Medicine Information (CMI) about Revatio intended for persons living in Australia.
  • News - 23 Oct 2024
    On 21 October, 14 patients and 10 caregivers were transferred from Kamal Adwan in North Gaza to Al-Shifa Hospital in Gaza City during a high-risk, WHO-led joint mission, amid intense hostilities and...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.